CVS Health Corporation (CVS)
| Market Cap | 72.21B |
| Revenue (ttm) | 360.94B |
| Net Income (ttm) | 7.32B |
| Shares Out | 1.26B |
| EPS (ttm) | 5.70 |
| PE Ratio | 10.09 |
| Forward PE | 7.82 |
| Dividend | $2.66 (4.62%) |
| Ex-Dividend Date | Apr 19, 2024 |
| Volume | 6,871,860 |
| Open | 58.04 |
| Previous Close | 58.15 |
| Day's Range | 57.23 - 58.22 |
| 52-Week Range | 52.77 - 83.25 |
| Beta | 0.52 |
| Analysts | Buy |
| Price Target | 76.10 (+32.3%) |
| Earnings Date | Jul 31, 2024 |
About CVS
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers phar... [Read more]
Financial Performance
In 2023, CVS Health's revenue was $357.78 billion, an increase of 10.95% compared to the previous year's $322.47 billion. Earnings were $8.34 billion, an increase of 93.55%.
Financial StatementsAnalyst Forecast
According to 21 analysts, the average rating for CVS stock is "Buy." The 12-month stock price forecast is $76.1, which is an increase of 32.30% from the latest price.
News
The Schall Law Firm Is Probing Allegations Related To CVS Health Corporation And Encourages Its Investors To Participate In The Investigation
LOS ANGELES, CA / ACCESSWIRE / July 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CVS Health Corpora...
The Schall Law Firm Is Conducting An Inquiry Into Matters Involving CVS Health Corporation And Urges Its Investors To Get Involved In The Investigation
LOS ANGELES, CA / ACCESSWIRE / July 1, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CVS Health Corpora...
Will CVS Stock Rebound To Levels Over $100 Seen In 2022?
CVS Health stock (NYSE: CVS) currently trades at $58 per share, 47% below its pre-inflation shock high of $110 seen in February 2022. In contrast, its peer – Walgreens stock – is down 75% over this pe...
CVS, Walgreens, Rite Aid closing stores: a brick and mortar downfall?
For years, U.S. pharmacy chains have been shuttering locations around the nation. It's a trend one industry expert says will continue, especially with the demand for online pharmacies.
These three healthcare stocks will benefit if Trump wins in 2024
The probability of Donald Trump returning to the White House currently sits at about 60%, as per Andrew Lilley – the chief interest rate strategist at Barrenjoey. And if Joe Biden's Republican rival d...
The Schall Law Firm Is Looking Into Claims Associated With CVS Health Corporation And Invites Its Investors To Engage In The Investigation
LOS ANGELES, CA / ACCESSWIRE / June 30, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CVS Health Corpor...
The Schall Law Firm Is Probing Accusations Concerning CVS Health Corporation And Calls On Its Investors To Be Part Of The Investigation
LOS ANGELES, CA /ACCESSWIRE / June 29, 2024 /The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CVS Health Corporat...
These 20 stocks have been the S&P 500's biggest losers so far in 2024
The S&P 500 is up nearly 16% so far this year with dividends reinvested. Artificial intelligence has been the big theme driving gains for Big Tech, especially Nvidia Corp. But 38% of the S&P 500 have ...
Medicare-related stocks rise after poor Biden debate performance
A select handful of health insurance names popped on Friday following the first debate between President Joe Biden and former President Donald Trump.
The Schall Law Firm Is Probing Allegations Related To CVS Health Corporation And Encourages Its Investors To Participate In The Investigation
LOS ANGELES, CA / ACCESSWIRE / June 28, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CVS Health Corpor...
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 3% Dividend Yields
During times of turbulence and uncertainty in the markets, even when markets are at all-time highs, many investors turn to dividend-yielding stocks. These are often companies that have high free cash ...
CVS Health stock price analysis as Walgreens implodes
CVS Health (NYSE: CVS) stock price is imploding as concerns about the pharmacy business continue. It has already plunged by more than 43% from its 2022 highs and is hovering at its lowest point since ...
The Schall Law Firm Is Examining Allegations Related To CVS Health Corporation And Encourages Its Investors To Participate In The Investigation
LOS ANGELES, CA / ACCESSWIRE / June 27, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CVS Health Corpor...
Stock Of The Day: It's No Coincidence CVS Health Stock Found Support Where It Did
CVS Health Corp CVS shares are getting crushed because of the terrible earnings report from Walgreens Boot Alliance. Inc. WBA.
The Schall Law Firm Is Investigating Claims Pertaining To CVS Health Corporation And Urges Its Investors To Join The Investigation
LOS ANGELES, CA / ACCESSWIRE / June 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CVS Health Corpor...
Investors Of CVS Health Corporation Are Encouraged To Participate In The Investigation As The Schall Law Firm Is Probing Allegations Related To It
LOS ANGELES, CA / ACCESSWIRE / June 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CVS Health Corpor...
Tecan appoints Mukta Acharya Head of the Life Sciences Business division
Tecan appoints Mukta Acharya Head of the Life Sciences Business division Männedorf, Switzerland, June 24, 2024 – The Tecan Group (SIX Swiss Exchange: TECN) announced today that Mukta Acharya, currentl...
CVS Health Corporation Investors Are Urged To Join The Investigation As The Schall Law Firm Is Investigating Claims Pertaining To It
LOS ANGELES, CA / ACCESSWIRE / June 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CVS Health Corpor...
CVS may soon show whether AI can start to replace call centers
Companies are increasingly turning to AI to see if it can improve the customer service experience. CVS plans to use AI so that pharmacy customers don't have to go through a menu option, per The Wall S...
The Schall Law Firm Is Investigating Claims Pertaining To CVS Health Corporation And Invites Its Shareholders To Join The Probe
LOS ANGELES, CA / ACCESSWIRE / June 20, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CVS Health Corpor...
Inside CVS's Strategy to Improve the Pharmacy Experience
When it comes to customer experience at the nation's largest retail pharmacy chains, there is plenty of room for improvement, according to Tilak Mandadi, the chief digital, data, analytics and technol...
The Schall Law Firm Is Investigating Claims Related To CVS Health Corporation And Invites Its Investors To Join The Probe
LOS ANGELES, CA / ACCESSWIRE / June 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CVS Health Corpor...
Allegations Pertaining To CVS Health Corporation (CVS) Are Being Probed By The Schall Law Firm And Investors Are Encouraged To Participate In The Investigation
LOS ANGELES, CA / ACCESSWIRE / June 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CVS Health Corpor...
The Schall Law Firm Is Launching A Probe Into Allegations Pertaining To CVS Health Corporation (CVS) And Encourages Investors To Participate In The Investigation
LOS ANGELES, CA / ACCESSWIRE / June 11, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CVS Health Corpor...
Is CVS Health a Buy as Wall Street Analysts Look Optimistic?
Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about CVS Health.